Yep - one of the top stock picks of 2011. Loads of positive press coming out about GLY. Target price some 70c in 12 months - triple your money anyone?
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%